Press Releases about Eli Lilly
![](https://www.marketbeat.com/logos/articles/med_20240701092712_eli-lillys-glp-1-drug-targets-huge-sleep-apnea-mar.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240624112813_the-top-3-sectors-poised-for-growth-this-summer.jpg)
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240619083908_eli-lillys-stock-surge-driven-by-glp-1-demand.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240618142245_alzheimers-drugs-stock-market-impact-and-uncertain.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240617124027_3-strong-buy-stocks-for-a-sizzling-summer-rally.jpg)
3 Strong Buy Stocks for a Sizzling Summer Rally
June 18, 2024
Via MarketBeat
![](https://www.marketbeat.com/logos/articles/med_20240602181915_hims-hers-health-soars-on-generic-glp-1-rollout-pl.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
Exposures
Product Safety
![](https://www.marketbeat.com/logos/articles/med_20240602172316_four-stocks-making-new-highs-despite-market-weakne.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240526193307_lifemd-can-surge-on-its-glp-1-offerings.jpg)
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Exposures
COVID-19
Via TheNewswire.com
Exposures
COVID-19
![](https://www.marketbeat.com/logos/articles/med_20240505185959_eli-lilly-gains-on-the-glp-1-weight-loss-phenomeno.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240501195747_3-staples-stocks-to-cushion-lower-consumer-sentime.jpg)
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240421190445_wegovy-vs.jpg)
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
April 18, 2024
Via AB Newswire
Topics
Economy
Exposures
Interest Rates
![](https://www.marketbeat.com/logos/articles/med_20240415000748_novo-nordisk-arms-wegovy-to-be-a-triple-threat.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240408193046_can-altimmune-get-its-glp-1-drug-to-market-before.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240408104424_will-the-shockwave-medical-deal-be-the-jolt-jnj-st.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240401200002_viking-therapeutics-surges-sentiment-for-triple-th.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240401130932_dexcom-stock-gains-from-glp-1-diabetic-users.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240327132929_7-stocks-that-will-drive-the-weight-loss-drugs-mar.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.